ACSL4 and inflammatory bowel disease: hucMSC-Ex alleviates IBD by acting on Acyl-CoA synthetase long-chain family member 4 (ACSL4) via miR-129-5p, leading to reduced levels of lipid peroxidation and ferroptosis, reduced inflammation, and damage repair [38].